Miscellaneous
Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment CME Available: https://auau.auanet.org/node/33917 At the conclusion of this course, participants will be able to: 1. Manage bleeding complications of robotic partial nephrectomy 2. Describe the algorithm of Immunotherapy treatment of advanced Renal Cell Carcinoma 3. Minimize positive margin rates of robotic partial nephrectomy ACKNOWLEDGEMENTS Independent educational grant support provided by: AstraZeneca Bristol-Myers Squibb Merck